Clinical Trials Directory

Trials / Sponsors / Blade Therapeutics

Blade Therapeutics

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
UnknownRESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 22022-05-31
CompletedDedicated Drug-Drug Interaction (DDI) Study in Healthy Volunteers
Drug Drug Interaction
Phase 12021-10-15
CompletedHealthy Volunteer Study Comparing Tablet and Oral Solution Formulations
Relative Bioavailability
Phase 12021-05-16
CompletedDrug-Drug Interaction (DDI) Study in Healthy Volunteers
Drug Drug Interaction
Phase 12021-05-03
WithdrawnHealthy Volunteer Study Comparing Tablet and Capsule Formulations
Fibrosis
Phase 12021-02-01
CompletedSafety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects
Sars-CoV-2, Covid19
Phase 22020-05-04
CompletedSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects
Chronic Liver Disease, NASH - Nonalcoholic Steatohepatitis
Phase 12020-01-10
WithdrawnSafety, Pharmacodynamics, and Pharmacokinetics of Orally Administered BLD-2660 in Subjects With IPF
Idiopathic Pulmonary Fibrosis
Phase 22019-12-15
CompletedFirst in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis
Fibrosis
Phase 12018-07-11